DLGAP1 and hepatocellular carcinoma: Moreover, it has been shown that cancer‐promoting effects of DLGAP1‐AS1 in HCC cells can happen through activating Wnt/β‐catenin pathway by positively regulating CDK8 and LRP6, downstream genes of miR‐26a/b‐5p.